Gross Margin
7.23%vs Specialty Chemicals peers Updated Aug 19, 2026Profit Margin
-0.51%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Margin
1.86%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Assets (TTM)
0.91%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Equity (TTM)
-0.81%vs Specialty Chemicals peers Updated Aug 19, 2026Revenue (TTM)
3.72BCNY552.97M · vs all stocks (USD) Updated Aug 19, 2026Revenue per Share (TTM)
7.53CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-2.00%vs Specialty Chemicals peers Updated Aug 19, 2026Gross Profit (TTM)
276.94MCNY41.13M · vs all stocks (USD) Updated Aug 19, 2026EBITDA (TTM)
328.01MCNY48.72M · vs all stocks (USD) Updated Aug 19, 2026Net Income (TTM)
-19.00MCNY-2.82M · vs all stocks (USD) Updated Aug 19, 2026Quarterly Earnings Growth (YoY)
-17.28%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Cash Flow (TTM)
121.87MCNY18.10M · vs all stocks (USD) Updated Aug 19, 2026Levered Free Cash Flow (TTM)
484.75MCNY72.00M · vs all stocks (USD) Updated Aug 19, 20265-Year Average Dividend Yield
1.28%Updated Aug 19, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 19, 2026Minority Interest (Equity)
95.74MCNYFY2025 · Dec 31, 2025Revenue
3.74BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.48BCNYFY2025 · Dec 31, 2025Gross Profit
257.12MCNYFY2025 · Dec 31, 2025Operating Income
53.93MCNY8.01M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-4.16MCNYFY2025 · Dec 31, 2025Income Tax Expense
30.91MCNYFY2025 · Dec 31, 2025Net Income
-35.07MCNYFY2025 · Dec 31, 2025EBIT
50.58MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
328.01MCNYFY2025 · Dec 31, 2025Research & Development
47.56MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
41.22MCNYFY2025 · Dec 31, 2025Other Operating Expenses
22.68MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.55MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
54.74MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0600CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
495.13MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
495.13MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-35.07MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
5.36MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-111.41MCNYFY2025 · Dec 31, 2025Free Cash Flow
-247.32MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
249.38MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-35.07MCNYFY2025 · Dec 31, 2025Other Non-cash Items
53.84MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-201.21MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
71.03MCNYFY2025 · Dec 31, 2025Capital Expenditures
-135.91MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.25MCNYFY2025 · Dec 31, 2025Sale of Investments
988.33KCNYFY2025 · Dec 31, 2025Other Investing Activity
-78.73MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-215.90MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
612.66MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-874.81MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-43.52MCNYFY2025 · Dec 31, 2025Other Financing Charges
401.23MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
95.56MCNYFY2025 · Dec 31, 2025